StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
603231.SS$16.36-2.04%
Fair $16.36+0.0%

603231.SS

Solbar Ningbo Protein Technology Co., Ltd.

Consumer Defensive / Packaged FoodsShanghai

$16.36

-0.34 (-2.04%)

Fairly Valued+0.0%Fair Value $16.36Fund rank 28/100 · Data gapFallback financials|
SA 34/D
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 20%

FCF escenarios

weak_data · normalized FCF $44.2M · quality 47.3/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 21/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

34/100

D

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 603231.SSLocal privado en este navegador · Solbar Ningbo Protein Technology Co., Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.1B

P/E

17.6x

↑

EV/EBITDA

9.7x

↑

ROE

9.5%

↑

Gross Margin

16.7%

↓

Debt/Equity

0.01

↓
52-Week Range$16
$16$22

TradingView lightweight chart

603231.SS price, volumen y niveles de valoración

Último $16.36Periodo -42.5%
Fair value: $16.36

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-1.8%

FCF CAGR

+42.0%

FCF margin

6.9%

FCF / Net income

0.64x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.75B · net income $189.7M · FCF $121.1M

2022-FY → 2025-FY

Gross margin

16.7%+3.4% pts

Operating margin

12.5%+2.4% pts

Net margin

10.9%+1.8% pts

FCF margin

6.9%+4.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.75B$1.75B$1.56B$1.75B$1.85B
Net Income$189.7M$189.7M$121.2M$146.0M$168.0M
EBITDA$302.2M$302.2M$214.2M$239.2M$253.8M
EPS——0.631.021.17
Gross Margin16.7%16.7%12.0%13.6%13.3%
Operating Margin12.5%12.5%7.9%10.4%10.1%
Net Margin10.9%10.9%7.8%8.3%9.1%
Balance Sheet
Debt/Equity0.010.010.010.040.11
Current Ratio6.226.22———
Cash Flow
Free Cash Flow$121.1M$121.1M$-20.8M$44.2M$42.3M
Returns
ROE9.5%9.5%6.5%7.5%20.9%
Valuation
P/E17.5917.5924.4624.11—
EV/EBITDA9.669.6612.4610.58—
P/B1.561.561.581.82—
Growth & Yield
Revenue Growth12.4%12.4%-11.0%-5.3%—
EPS Growth——-38.2%-12.8%—
Dividend Yield2.2%2.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -5.1%

Total return

-5.1%

Start / end P/E

n/dx → n/dx

EPS bridge

0.63 → n/d

Residual

-7.4%

EPS growthn/d
Multiple reratingn/d
Dividend+2.2%
Residual / FX / buybacks / cross-term-7.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.